A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/1998
10/22/1998	WO1998002190A3 Cationic amphiphile/dna complexes
10/22/1998	CA2286692A1 Polymeric conjugates polyvalently presenting an agent for therapy
10/22/1998	CA2285705A1 Selective factor xa inhibitors
10/22/1998	CA2285685A1 Selective factor xa inhibitors
10/22/1998	CA2285659A1 Selective factor xa inhibitors
10/22/1998	CA2285335A1 Selective factor xa inhibitors
10/22/1998	CA2284127A1 Flt3 ligand chimeric proteins
10/22/1998	CA2234399A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
10/22/1998	CA2231740A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
10/21/1998	EP0872245A1 Methods for treating vascular disorders with activated Protein C
10/21/1998	EP0871748A2 Delivery of biologically active polypeptides
10/21/1998	EP0871732A1 Method of treating sepsis
10/21/1998	EP0871672A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
10/21/1998	EP0871670A2 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR
10/21/1998	EP0871664A1 Novel chemokine for mobilizing stem cells
10/21/1998	EP0871606A1 New compounds and their compositions having anti-inflammatory and anti-thrombotic activities
10/21/1998	EP0871477A1 Method for obtaining receptor agonist antibodies
10/21/1998	EP0871476A1 Dried blood factor composition comprising trehalose
10/21/1998	EP0871464A1 Bradykinin analogs as selective thrombin inhibitors
10/21/1998	EP0871457A1 Isolated stromal cells and methods of using the same
10/21/1998	EP0871433A2 Composition for sustained release of non-aggregated erythropoietin
10/21/1998	EP0706517B1 Pyridazinone derivatives with pharmaceutical activity
10/21/1998	CN1196731A Diglycosylated 1,2-diols as mimetics of sialyl-lewis X and sialyl-Lewis A analogies
10/21/1998	CN1196240A Heme antianemia medicine and preparation method
10/20/1998	US5824784 Genetic engineering with polypeptides and proteins
10/20/1998	US5824679 Thrombin inhibitors; anticoagulants; cardiovascular disorders, arteriosclerosis; antitumor agents
10/20/1998	US5824639 Modified factor VII anticoagulant proteins
10/20/1998	US5824492 Polypeptides having kinase activity, their preparation and use
10/20/1998	US5824304 Peripheralization of hematopoietic stem cells
10/20/1998	US5824303 Dna sequence encoding, proteins and peptides
10/20/1998	CA1340096C Analogs of atrial natriuretic peptides
10/15/1998	WO1998045712A2 20 human secreted proteins
10/15/1998	WO1998045335A1 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation
10/15/1998	WO1998045268A1 Nicotinamide derivatives
10/15/1998	WO1998044942A1 Immunotolerant prothrombin complex preparation
10/15/1998	WO1998044941A1 Method for inactivating pathogens, especially viruses, in a biological material
10/15/1998	WO1998030589A3 Secreted proteins and polynucleotides encoding them
10/15/1998	WO1998022500A3 Modulation of interactions between myosin and integrins
10/15/1998	WO1998017810A3 Multi-functional chimeric hematopoietic receptor agonists
10/15/1998	DE19715504A1 PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen PMMA membranes with polyethylene glycol-coupled active substances
10/15/1998	DE19715149A1 Krebstherapeutikum und Diagnose zur Charakterisierung von Krebszellen mit individueller Eigenschaft Cancer therapy and diagnosis for the characterization of cancer cells with individual property
10/15/1998	CA2286303A1 20 human secreted proteins
10/15/1998	CA2285976A1 Method for inactivating pathogens, especially viruses, in a biological material
10/14/1998	EP0870027A1 Novel c-mpl receptor agonists
10/14/1998	EP0869966A1 Prodrugs of thrombin inhibitors
10/14/1998	EP0869944A1 N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS
10/14/1998	EP0869793A1 Hemoregulatory compounds
10/14/1998	EP0869790A1 THIENO(2,3-b)PYRAZOLO(3,4-d)PYRIDIN-3-ONES TO ENHANCE ERYTHROPOIESIS
10/14/1998	EP0693930B1 Use of colloidal silicon dioxide for treating sickle-cell anemia, malaria and exogenously induced leukopenias
10/14/1998	EP0673388B1 Double chain peptide compounds having hemoregulatory activity
10/14/1998	CN1195701A Antihumanfibrin monoclonal antibody heavy chain and light chain variable region gene and its application
10/14/1998	CN1195662A New benzenesulfonylamine compounds, process for preparating them and pharmaceutical compositions containing them
10/14/1998	CN1040210C Fused benzazepine derivative and pharmaceutical composition containing the same
10/13/1998	US5821351 Chimeric human globin gene
10/13/1998	US5821264 Used in foodstuffs and dietary supplements to decrease lipoprotein concentration or increase feed conversion
10/13/1998	US5821123 Modified antibody variable domains
10/13/1998	US5821106 Salmonase prepared from a korean viper
10/08/1998	WO1998044000A1 Recombinant protein c and protein s variants
10/08/1998	WO1998043631A1 Mixture of primary fatty acids obtained from sugar cane wax
10/08/1998	WO1998043618A2 Use of cytoskeletal inhibitors for the prevention of restenosis
10/08/1998	CA2283934A1 Recombinant protein c and protein s variants
10/07/1998	EP0869178A1 SAF-3, Sialoadhesin family member-3
10/07/1998	EP0868521A2 Globins containing binding domains
10/07/1998	EP0868194A1 Combination of g-csf with a chemotherapeutic agent for stem cell mobilisation
10/07/1998	EP0868191A1 Potentiation of complement and coagulation inhibitory properties of c1-inhibitor.
10/07/1998	EP0703923B1 Factor vii-derived peptides
10/07/1998	CN1195354A New thrombin inhibitors their preparation and use
10/07/1998	CN1195353A New inhibitors of platelet aggregation
10/07/1998	CN1195348A New oxazolidinone derivatives, process for preparing same and medicaments contain these compounds
10/07/1998	CN1195291A Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
10/06/1998	US5817749 Cyclic pentapeptides
10/06/1998	US5817677 5-membered heterocycles, medicaments containing these compounds, their use and processes for their preparation
10/06/1998	US5817643 Immunostimulants
10/06/1998	US5817622 Cloning dna sequences
10/06/1998	US5817486 Recombinant human interleukin-3 (IL-3) multiple mutation polypeptides
10/06/1998	US5817485 Nucleic acids and cells for recombinant production of fibroblast growth factor-10
10/06/1998	US5817309 Antidote for hirudin and synthetic thrombin inhibitors and method of use
10/02/1998	CA2233787A1 Sialoadhesin family member-3
10/01/1998	WO1998042850A1 Anticoagulant fusion protein anchored to cell membrane
10/01/1998	WO1998042834A1 Bi- or multifunctional molecules based on a dendroaspin scaffold
10/01/1998	WO1998042754A2 Glycosaminoglycans having high antithrombotic activity
10/01/1998	WO1998042745A1 Iron-casein complex and process for preparing the same
10/01/1998	WO1998042739A2 Secreted proteins and polynucleotides encoding them
10/01/1998	WO1998042738A1 87 human secreted proteins
10/01/1998	WO1998042687A1 Lipase catalyzed dynamic resolution of isoxazoline thioesters to isoxazoline carboxylic acids
10/01/1998	WO1998042358A1 Methods for treating vascular disorders
10/01/1998	WO1998042342A1 Thrombin inhibitors
10/01/1998	CA2285702A1 Anticoagulant fusion protein anchored to cell membrane
10/01/1998	CA2284550A1 87 human secreted proteins
10/01/1998	CA2284279A1 Methods for treating vascular disorders
10/01/1998	CA2284095A1 Bi- or multifunctional molecules based on a dendroaspin scaffold
10/01/1998	CA2283704A1 Thrombin inhibitors
10/01/1998	CA2283631A1 Secreted proteins and polynucleotides encoding them
10/01/1998	CA2283234A1 Lipase catalyzed dynamic resolution of isoxazoline thioesters to isoxazoline carboxylic acids
09/1998
09/30/1998	EP0867513A2 Interleukin-1 beta converting enzyme apoptosis protease-10
09/30/1998	EP0866806A1 Method of mobilizing hematopoietic stem cells
09/30/1998	EP0866722A1 Improved formulation for administration of steroid compounds
09/30/1998	EP0866705A1 Fibrinogen receptor antagonists
09/30/1998	EP0866700A1 Hemoregulatory compounds
09/30/1998	EP0866698A1 Hemoregulatory compounds

1 ... 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 ... 671